Danaher Corp
Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –
Danaher Diagnostics by Year
Diagnostics — Price Realization (reflecting China VBP centralized procurement) (%)
Danaher Diagnostics: -1.0% in FY2025.
Where the FY2025 figure comes from
“Price decreases in the segment of 1.0%, primarily attributable to the volume-based procurement program and healthcare reimbursement changes in China and to a lesser extent, sales promotions, negatively impacted the year-over-year change in sales during 2025 and are reflected as a component of core sales above.”
Source: Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗
Reported for Q1, Q2, Q3 (10-Q) and full year (10-K), with no standalone Q4 reported. Directly reflects price reductions from the volume-based procurement (VBP) program and medical insurance reimbursement reforms in China (-2.0% Q1, -1.5% Q2, -1.0% Q3 2026).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Diagnostics — Price Realization (reflecting China VBP centralized procurement) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -1.0% | – | Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗ |
| FY2023 | Dec 31, 2023 | 1.0% | 0.0 pts | Danaher SEC 10-K (FY2023, filed 2024-02-21) ↗ |
| FY2022 | Dec 31, 2022 | 1.0% | +0.5 pts | Danaher SEC 10-K (FY2022, filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 0.5% | -1.0 pts | Danaher SEC 10-K (FY2021, filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 1.5% | – | Danaher SEC 10-K (FY2020, filed 2021-02-25) ↗ |
Cite this data
StockData. (2026). Danaher Diagnostics (%), annual FY2020–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/mda-price-impact-diag
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.